Kathleen K Schoemaker's Net Worth

$328 Million

Estimate Recalculated Feb 27, 2024 09:33PM EST

Who is Kathleen K Schoemaker?

Kathleen K Schoemaker has an estimated net worth of $328 Million. This is based on reported shares across multiple companies, which include CoLucid Pharmaceuticals, Inc., MARINUS PHARMACEUTICALS INC, GLAUKOS Corp, Atara Biotherapeutics, Inc., Aldeyra Therapeutics, Inc., aTYR PHARMA INC, OTONOMY, INC., Neothetics, Inc., Durata Therapeutics, Inc., CADENCE PHARMACEUTICALS INC, Regado Biosciences Inc, Esperion Therapeutics, Inc., Clovis Oncology, Inc., ALIMERA SCIENCES INC, Evoke Pharma Inc, VERACYTE, INC., Dicerna Pharmaceuticals Inc, Volcano Corp, Orexigen Therapeutics, Inc., ZOGENIX, INC., Northstar Neuroscience, Inc., INTRALASE CORP, IOMAI CORP, TANDEM DIABETES CARE INC, Vanda Pharmaceuticals Inc., NUVASIVE INC, Transcept Pharmaceuticals Inc, REVA Medical, Inc., SENOMYX INC, Ocera Therapeutics, Inc., Achaogen Inc, ACHILLION PHARMACEUTICALS INC, Celator Pharmaceuticals Inc, SANTARUS INC, Somaxon Pharmaceuticals, Inc., and SENORX INC.

SEC CIK

Kathleen K Schoemaker's CIK is 0001207789

Past Insider Trading and Trends

2010 was Kathleen K Schoemaker's most active year for acquiring shares with 36 total transactions. Kathleen K Schoemaker's most active month to acquire stocks was the month of October. 2014 was Kathleen K Schoemaker's most active year for disposing of shares, totalling 74 transactions. Kathleen K Schoemaker's most active month to dispose stocks was the month of October. 2011 saw Kathleen K Schoemaker paying a total of $26,590,082.18 for 7,499,108 shares, this is the most they've acquired in one year. In 2006 Kathleen K Schoemaker cashed out on 30,652,100 shares for a total of $51,028,309.20, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

CoLucid Pharmaceuticals, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
3.52K
3.52K
May 11
Form 4
+5,043.01%
2.2M
2.25M
May 11
Form 3
0
0
Form 3
0
0
No matching records found

MARINUS PHARMACEUTICALS INC (MRNS) Snapshot price: $9.945

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
17K
17K
Aug 5
Form 4
2.48M
$8.00
$3,357,952.00
2.48M
Aug 5
Form 3
0
0
Form 3
0
0
Form 3
0
0
No matching records found

GLAUKOS Corp (GKOS) Snapshot price: $94.73

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
876.08K
876.08K
Jun 30
Form 4
6.5K
6.5K
Jun 30
Form 4
2.07M
$12.83
-$156,600.00
2.07M
Jun 30
Form 4
14.04K
14.04K
Jun 30
Form 3
0
0
Form 3
0
0
Form 3
0
0
Form 3
0
0
Form 3
0
0
No matching records found

Atara Biotherapeutics, Inc. (ATRA) Snapshot price: $1.06

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
15.89K
$11.00
15.89K
Oct 21
Form 4
2.14M
$11.00
2.14M
Oct 21
Form 3
0
0
Form 3
0
0
No matching records found

Aldeyra Therapeutics, Inc. (ALDX) Snapshot price: $3.25

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+1.09%
21.25K
1.97M
May 7
Form 4
9.21K
9.21K
May 1
Form 4
1.95M
$6.58
$136.32
1.95M
May 1
Form 3
0
0
Form 3
0
0
Form 3
0
0
No matching records found